跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 343 条关于
“LiCO-saUcp1”
全部
343
临床试验
280
药物
21
机构
22
资讯
20
3个月前
Ractigen's saRNA Candidate LiCO-saUcp1 Demonstrates High-Quality Weight Loss Without Muscle Wasting or Rebound in Preclinical Obesity Models
上个月
Ractigen Therapeutics Secures U.S. FDA IND Clearance for First-in-Class saRNA Therapy RAG-1C Targeting Proliferative Vitreoretinopathy
9个月前
Ractigen Therapeutics Initiates First-in-Human Trial of RAG-18 for Duchenne Muscular Dystrophy
上个月
Ractigen Therapeutics Closes $31M+ Financing to Advance saRNA Pipeline and Extrahepatic Delivery Platforms
去年
St. Luke's Surgeon Stan Stawicki Recognized for Contributions to Clinical Research
2年前
Lisocabtagene Maraleucel Shows Consistent Benefit in High-Risk CLL Subgroups
去年
Liso-cel Demonstrates Significant Response in Relapsed/Refractory Marginal Zone Lymphoma
去年
Vico Therapeutics' VO659 Shows Promise in Huntington's Disease and Spinocerebellar Ataxias
2年前
Liso-Cel CAR-T Therapy Shows Promising Results Across Multiple Lymphoma Subtypes
去年
Liso-cel Achieves 95.5% Response Rate in Relapsed/Refractory Marginal Zone Lymphoma
第 1 页,共 2 页
上一页
下一页